TY - JOUR
T1 - The two faces of fractionated photodynamic therapy
T2 - Increasing efficacy with light fractionation or adjuvant use of fractional laser technology
AU - Juhasz, Margit L.W.
AU - Levin, Melissa K.
AU - Marmur, Ellen S.
N1 - Publisher Copyright:
Copyright © 2016 Journal of Drugs in Dermatology.
PY - 2016/11
Y1 - 2016/11
N2 - "Fractionated photodynamic therapy (PDT)" is a new term being used by dermatologists to describe advances in PDT technology including fractionated light or the adjuvant use of fractional lasers. Although dermatologists have used PDT since the early 1990s for the treatment of photodamage and precancerous lesions, newer developments in technology have allowed for the treatment of non-melanoma skin cancers (NMSCs), in ammatory disorders, and even uses in the eld of anti-aging. Recent developments in fractionated light therapy have allowed for PDT with dark intervals and two-fold illumination schemes to increase cellular damage and apoptosis. Combining PDT with fractional laser technology has allowed for enhanced dermal penetration of topical photosensitizers including 5-aminolevulinic acid (ALA) and methyl aminolevulinate (MAL), as well as increased ef cacy of treatment. These advances in PDT technology will allow for increased convenience, decreased treatment time, only one application of topical photosensitizer, and decreased cost to the patient and dermatologist.
AB - "Fractionated photodynamic therapy (PDT)" is a new term being used by dermatologists to describe advances in PDT technology including fractionated light or the adjuvant use of fractional lasers. Although dermatologists have used PDT since the early 1990s for the treatment of photodamage and precancerous lesions, newer developments in technology have allowed for the treatment of non-melanoma skin cancers (NMSCs), in ammatory disorders, and even uses in the eld of anti-aging. Recent developments in fractionated light therapy have allowed for PDT with dark intervals and two-fold illumination schemes to increase cellular damage and apoptosis. Combining PDT with fractional laser technology has allowed for enhanced dermal penetration of topical photosensitizers including 5-aminolevulinic acid (ALA) and methyl aminolevulinate (MAL), as well as increased ef cacy of treatment. These advances in PDT technology will allow for increased convenience, decreased treatment time, only one application of topical photosensitizer, and decreased cost to the patient and dermatologist.
UR - http://www.scopus.com/inward/record.url?scp=85021848484&partnerID=8YFLogxK
M3 - Article
C2 - 28095542
AN - SCOPUS:85021848484
SN - 1545-9616
VL - 15
SP - 1324
EP - 1328
JO - Journal of Drugs in Dermatology
JF - Journal of Drugs in Dermatology
IS - 11
ER -